This announcement is a separate document:
巨子生物：(1)建議採納股份計劃及(2)有關截至2022 年12月31日止年度年度報告的補充資料
GIANT BIOGENE: (1) PROPOSED ADOPTION OF SHARE SCHEMESAND(2) SUPPLEMENTAL INFORMATION IN RELATION TOANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.